应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RDC 罗文
退市 07-17 07:21:36 EDT
10.93
+0.00
0.00%
最高
10.93
最低
10.93
成交量
0.00
今开
10.93
昨收
10.93
日振幅
0.00%
总市值
13.91亿
流通市值
11.58亿
总股本
1.27亿
成交额
0.00
换手率
0.00%
流通股本
1.06亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
汇隆控股(08021):罗文生已辞任独立非执行董事
智通财经 · 07-16 18:32
汇隆控股(08021):罗文生已辞任独立非执行董事
本周新发基金15只:华夏广发南方等13家基金公司pk 金拓、罗文杰、霍华明等竞技
新浪基金 · 06-11
本周新发基金15只:华夏广发南方等13家基金公司pk 金拓、罗文杰、霍华明等竞技
7年上涨100倍!核药公司Telix宣布IPO
智通财经网 · 06-10
7年上涨100倍!核药公司Telix宣布IPO
环球数码创意(08271):罗文钰退任独立非执行董事
智通财经 · 05-24
环球数码创意(08271):罗文钰退任独立非执行董事
天韵国际控股(06836):罗文僖获委任为公司秘书及授权代表之一
智通财经 · 05-21
天韵国际控股(06836):罗文僖获委任为公司秘书及授权代表之一
港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)
媒体滚动 · 05-03
港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)
国美金融科技(00628):罗文钰已获委任为独立非执行董事
智通财经 · 04-10
国美金融科技(00628):罗文钰已获委任为独立非执行董事
全球核药领军企业再传喜讯,远大医药(00512)创新RDC ITM-11国内III期临床获批
智通财经 · 03-24
全球核药领军企业再传喜讯,远大医药(00512)创新RDC ITM-11国内III期临床获批
国内最强核药发动机,满手王炸
瞪羚社 · 03-20
国内最强核药发动机,满手王炸
加载更多
公司概况
公司名称:
罗文
所属市场:
NYSE
上市日期:
--
主营业务:
罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。
发行价格:
--
{"stockData":{"symbol":"RDC","market":"US","secType":"STK","nameCN":"罗文","latestPrice":10.93,"timestamp":1575925200000,"preClose":10.93,"halted":4,"volume":0,"delay":0,"floatShares":105959169,"shares":127294643,"eps":-2.74,"marketStatus":"退市","marketStatusCode":1,"change":0,"latestTime":"07-17 07:21:36 EDT","open":10.93,"high":10.93,"low":10.93,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.74,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721223000000},"adr":0,"listingDate":-73684800000,"adjPreClose":10.93,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/RDC","defaultTab":"news","newsList":[{"id":"2451964713","title":"汇隆控股(08021):罗文生已辞任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2451964713","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451964713?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:32","pubTimestamp":1721125937,"startTime":"0","endTime":"0","summary":"智通财经APP讯,汇隆控股(08021)发布公告,由于需要投入更多时间处理个人事务,罗文生已辞任独立非执行董事、公司审核委员会成员及公司薪酬委员会主席,自2024年7月16日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151639.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","BK1148","08021","RDC"],"gpt_icon":0},{"id":"2442334857","title":"本周新发基金15只:华夏广发南方等13家基金公司pk 金拓、罗文杰、霍华明等竞技","url":"https://stock-news.laohu8.com/highlight/detail?id=2442334857","media":"新浪基金","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442334857?lang=zh_cn&edition=full","pubTime":"2024-06-11 14:05","pubTimestamp":1718085900,"startTime":"0","endTime":"0","summary":" 6月11日,本周15只新基金将同台竞技,涉及易方达、广发、华夏、 南方、景顺长城、鹏华、华安、兴银、富安达等13家基金公司。从基金投资类型来看,主要为指数型、公募REITs和混合型产品。基金经理过往业绩不代表未来产品业绩的预示或预测。股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/original/2024-06-11/doc-inayixue3951079.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/original/2024-06-11/doc-inayixue3951079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2442894389","title":"7年上涨100倍!核药公司Telix宣布IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2442894389","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442894389?lang=zh_cn&edition=full","pubTime":"2024-06-10 10:48","pubTimestamp":1717987703,"startTime":"0","endTime":"0","summary":"6月5日,专注于放射性核素偶联药物(RDC)领域的生物制药公司Telix Pharmaceuticals披露了首次公开募股(IPO)的条款,计划在纳斯达克上市。","market":"hk","thumbnail":"http://img.zhitongcaijing.com/source/image/23657.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["http://img.zhitongcaijing.com/source/image/23657.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1133163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IPO","RDC"],"gpt_icon":0},{"id":"2437088806","title":"环球数码创意(08271):罗文钰退任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2437088806","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437088806?lang=zh_cn&edition=full","pubTime":"2024-05-24 17:01","pubTimestamp":1716541294,"startTime":"0","endTime":"0","summary":"智通财经APP讯,环球数码创意(08271)发布公告,罗文钰(“罗教授”)于股东周年大会结束后,已退任公司独立非执行董事一职,以便投入更多时间于其个人事务。紧随罗教授的退任,彼亦不再担任公司薪酬委员会的主席以及审核委员会及提名委员会的成员,自股东周年大会结束起生效。为表彰罗教授在任职期间对公司的贡献,董事会委任罗教授于2024年5月24日退任独立非执行董事后出任公司的名誉顾问。紧随罗教授的退任,独立非执行董事李尧已获委任为审核委员会的成员、独立非执行董事吴春华已获委任为提名委员会的成员及薪酬委员会的主席。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RDC","BK1128","08271"],"gpt_icon":0},{"id":"2437491221","title":"天韵国际控股(06836):罗文僖获委任为公司秘书及授权代表之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2437491221","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437491221?lang=zh_cn&edition=full","pubTime":"2024-05-21 17:27","pubTimestamp":1716283651,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天韵国际控股(06836)发布公告,何浩东已提出辞任彼首席财务官;公司秘书;及上市规则第 3.05 条项下的公司授权代表职务,自2024年5月17日起生效,以投入更多时间追求及发展个人兴趣。彼辞任后,彼亦不再担任公司策略发展及投资委员会成员的职务。公告称,委任罗文僖为公司的公司秘书及授权代表之一,均由2024年5月17日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","06836","RDC"],"gpt_icon":0},{"id":"2432995389","title":"港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2432995389","media":"媒体滚动","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432995389?lang=zh_cn&edition=full","pubTime":"2024-05-03 09:21","pubTimestamp":1714699260,"startTime":"0","endTime":"0","summary":"5月1日21时18分,经过二十一天的奋战,中核集团旗下中国核电投资控股的秦山核电在线辐照生产医用同位素装置顺利完成系统标识和送电试验,标志着该套装置已按计划全面建成,至此,我国掌握了批量化在线辐照生产同位素的关键技术,镥-177、锶-89和钇-90等多种国内当前紧缺的短半衰期医用同位素将在今年下半年配套厂房建成投产后进入规模化生产阶段。","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-03/doc-inatxcqa7962160.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-03/doc-inatxcqa7962160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01763","00512","BK1191","RDC","BK1222"],"gpt_icon":0},{"id":"2426253468","title":"国美金融科技(00628):罗文钰已获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2426253468","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426253468?lang=zh_cn&edition=full","pubTime":"2024-04-10 18:05","pubTimestamp":1712743554,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国美金融科技(00628)发布公告,罗文钰已获委任为独立非执行董事、公司审核委员会成员及公司战略委员会成员,自2024年4月10日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1218","BK1186","RDC","00628"],"gpt_icon":0},{"id":"2421232674","title":"全球核药领军企业再传喜讯,远大医药(00512)创新RDC ITM-11国内III期临床获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2421232674","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421232674?lang=zh_cn&edition=full","pubTime":"2024-03-24 18:24","pubTimestamp":1711275862,"startTime":"0","endTime":"0","summary":"3月24日晚,公司公布其用于治疗胃肠胰腺神经内分泌瘤的全球创新放射性核素偶联药物 ITM-11近日已获得国家药监局批准开展III期临床研究。实际上,远大医药早在2018年即已布局核药领域及RDC赛道。目前,公司已有4款创新RDC药物在国内获批开展临床研究,其中3款已进入III期临床阶段,包括诊断前列腺癌的产品TLX591-CDx、诊断透明细胞肾细胞癌产品 TLX250-CDx,以及治疗GEP-NETs的产品ITM-11。远大医药表示,公司目前正在有序推进国内甲级资质核素生产平台的建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ITM","BK1191","00512","BK4134","RDC","III"],"gpt_icon":0},{"id":"2420112757","title":"国内最强核药发动机,满手王炸","url":"https://stock-news.laohu8.com/highlight/detail?id=2420112757","media":"瞪羚社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420112757?lang=zh_cn&edition=full","pubTime":"2024-03-20 18:20","pubTimestamp":1710930000,"startTime":"0","endTime":"0","summary":"继诺华、Lantheus和Telix等以核药布局领先而闻名的巨头们财报大超预期后,国内核药领头羊远大医药同样不负众望交出了靓丽的成绩单。 3月20日,远大医药发布2023年度业绩:公司实现....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/Ongg31_OvTHKV4X_KfD6Tklb2PvYIifysFS0Y09IX_kFgAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Ongg31_OvTHKV4X_KfD6Tklb2PvYIifysFS0Y09IX_kFgAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240320A08AFN00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240320A08AFN00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4135","AR","BK4213","SAR","RDC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rowan.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。","exchange":"NYSE","name":"罗文","nameEN":"Rowan Companies PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗文,RDC,罗文股票,罗文股票老虎,罗文股票老虎国际,罗文行情,罗文股票行情,罗文股价,罗文股市,罗文股票价格,罗文股票交易,罗文股票购买,罗文股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}